Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11897)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 21, 2018 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Noureddin M, Wong MM, Todo T, Lu SC, Sanyal AJ, Mena EA. Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals. World J Gastroenterol 2018; 24(11): 1269-1277 [PMID: 29568207 DOI: 10.3748/wjg.v24.i11.1269] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i11/1269.htm |
| Number | Citing Articles |
| 1 |
Annelys Roque Gardner, Yifei Ma, Peter Bacchetti, Jennifer C Price, Mark H Kuniholm, Audrey L French, Stephen Gange, Adaora A Adimora, Howard Minkoff, Seble Kassaye, Igho Ofotokun, William Rosenberg, Andrea A Z Kovacs, Phyllis C Tien. Longitudinal Assessment of the Enhanced Liver Fibrosis Score in the Era of Contemporary HIV and Hepatitis C Virus Treatment. The Journal of Infectious Diseases 2023; 227(11): 1274 doi: 10.1093/infdis/jiac315
|
| 2 |
Jaeseo Lee, Dayeon Gil, Hyeyeon Park, Youngsun Lee, Seon Ju Mun, Yongbo Shin, Eunji Jo, Marc P. Windisch, Jung-Hyun Kim, Myung Jin Son. A multicellular liver organoid model for investigating hepatitis C virus infection and nonalcoholic fatty liver disease progression. Hepatology 2024; 80(1): 186 doi: 10.1097/HEP.0000000000000683
|
| 3 |
Andrew H. Talal, Yuxin Ding, Charles S. Venuto, Lindsay M. Chakan, Anthony McLeod, Arpan Dharia, Gene D. Morse, Lawrence S. Brown, Marianthi Markatou, Evan D. Kharasch, Wenyu Lin. Toward precision prescribing for methadone: Determinants of methadone deposition. PLOS ONE 2020; 15(4): e0231467 doi: 10.1371/journal.pone.0231467
|
| 4 |
M. Santos, A. Corma-Gómez, M. Fernandez-Fuertes, A. González-Serna, P. Rincón, L.M. Real, J.A. Pineda, J. Macías. Burden of significant liver damage in people living with HIV after microelimination of the hepatitis C virus. Journal of Infection 2023; 86(1): 41 doi: 10.1016/j.jinf.2022.11.004
|
| 5 |
Anca Trifan, Ermina Stratina, Adrian Rotaru, Remus Stafie, Sebastian Zenovia, Robert Nastasa, Laura Huiban, Catalin Sfarti, Camelia Cojocariu, Tudor Cuciureanu, Cristina Muzica, Stefan Chiriac, Irina Girleanu, Ana-Maria Singeap, Carol Stanciu. Changes in Liver Steatosis Using Controlled Attenuation Parameter among Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals Therapy Who Achieved Sustained Virological Response. Diagnostics 2022; 12(3): 702 doi: 10.3390/diagnostics12030702
|
| 6 |
Frank Tacke, Klaus H.W. Boeker, Hartwig Klinker, Renate Heyne, Peter Buggisch, Anita Pathil, Johannes Wiegand, Markus Cornberg, Christian Lange, Thomas Berg, Stefan Zeuzem, Stefan Mauss. Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs. Liver International 2020; 40(3): 539 doi: 10.1111/liv.14186
|
| 7 |
Frank Tacke, Hartwig Klinker, Klaus H. W. Boeker, Uta Merle, Ralph Link, Peter Buggisch, Dietrich Hüppe, Markus Cornberg, Christoph Sarrazin, Heiner Wedemeyer, Thomas Berg, Stefan Mauss. Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C‐Registry. Hepatology Communications 2022; 6(9): 2488 doi: 10.1002/hep4.2015
|
| 8 |
Chen-Hua Liu, Pin-Nan Cheng, Yu-Jen Fang, Chi-Yi Chen, Wei-Yu Kao, Chih-Lin Lin, Sheng-Shun Yang, Yu-Lueng Shih, Cheng-Yuan Peng, Yu-Ping Chang, Shang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, Chun-Jen Liu, Pei-Jer Chen, Jia-Horng Kao. Risk of de novo HCC in patients with MASLD following direct-acting antiviral-induced cure of HCV infection. Journal of Hepatology 2024; doi: 10.1016/j.jhep.2024.09.038
|
| 9 |
Yasser Fouad, Gamal Esmat, Reda Elwakil, Serag Zakaria, Ayman Yosry, Imam Waked, Maissa El-Razky, Wahid Doss, Magdy El-Serafy, Ebraheem Mostafa, Mahmood Anees, Mohamed A. Sakr, Nadia AbdelAty, Ashraf Omar, Samy Zaki, Amgad Al-zahaby, Hamdy Mahfouz, Maysaa Abdalla, Mahmoud Albendary, Abdel-Khalek Hamed, Ahmed Gomaa, Adel Hasan, Sherif Abdel-baky, Medhat El sahhar, Gamal Shiha, Dina Attia, Ebada Saeed, Enas Kamal, Shamardan Bazeed, Mai Mehrez, Shereen Abdelaleem, Yasmine Gaber, Mohammed Abdallah, Asmaa Salama, Doaa A. Tawab, Shaymaa Nafady. The Egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Saudi Journal of Gastroenterology 2022; 28(1): 3 doi: 10.4103/sjg.sjg_357_21
|
| 10 |
James McPhail, Omar T. Sims, Yuqi Guo, David Wooten, John S. Herndon, Omar I. Massoud. Fibrosis improvement in patients with HCV treated with direct-acting antivirals. European Journal of Gastroenterology & Hepatology 2021; 33(7): 996 doi: 10.1097/MEG.0000000000001821
|
| 11 |
Bernhard Schlevogt, Klaus H. W. Boeker, Stefan Mauss, Hartwig Klinker, Renate Heyne, Ralph Link, Karl-Georg Simon, Christoph Sarrazin, Yvonne Serfert, Michael P. Manns, Heiner Wedemeyer. Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R). Biomedicines 2021; 9(10): 1495 doi: 10.3390/biomedicines9101495
|
| 12 |
Mohammed Eslam, Shiv K. Sarin, Vincent Wai-Sun Wong, Jian-Gao Fan, Takumi Kawaguchi, Sang Hoon Ahn, Ming-Hua Zheng, Gamal Shiha, Yusuf Yilmaz, Rino Gani, Shahinul Alam, Yock Young Dan, Jia-Horng Kao, Saeed Hamid, Ian Homer Cua, Wah-Kheong Chan, Diana Payawal, Soek-Siam Tan, Tawesak Tanwandee, Leon A. Adams, Manoj Kumar, Masao Omata, Jacob George. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatology International 2020; 14(6): 889 doi: 10.1007/s12072-020-10094-2
|
| 13 |
Natthaya Chuaypen, Surachate Siripongsakun, Pantajaree Hiranrat, Natthaporn Tanpowpong, Anchalee Avihingsanon, Pisit Tangkijvanich, Jee-Fu Huang. Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants. PLOS ONE 2022; 17(6): e0269641 doi: 10.1371/journal.pone.0269641
|
| 14 |
Kymberly D. Watt, Sonali Paul, Mohammad Qasim Khan, Mohammad Siddiqui, Jenny Lam, Tayyab S. Diwan, Michael Camilleri. Obesity management for the hepatologist—What to do, how to do it and why?. Hepatology 2023; doi: 10.1097/HEP.0000000000000598
|
| 15 |
Yasser Fouad, Jeffrey V. Lazarus, Francesco Negro, Markus Peck‐Radosavljevic, Shiv K. Sarin, Peter Ferenci, Gamal Esmat, Hasmik Ghazinian, Atsushi Nakajima, Marcelo Silva, Samuel Lee, Massimo Colombo. MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective. Alimentary Pharmacology & Therapeutics 2021; 53(10): 1080 doi: 10.1111/apt.16346
|
| 16 |
Thais Pontello de Vries, Aline Marcos Pires, Kiara Gonçalves Dias Diniz, Anna Luiza Soares Chagas, Diego Alves Vieira, Adriana Maria Kakehasi, Vivian Marques Miguel Suen, Tatiana Bering, Enrico Antonio Colosimo, Gifone Aguiar Rocha, Kátia de Paula Farah, Luciana Diniz Silva. Agreement and diagnostic differences among three definitions of sarcopenia in patients with chronic hepatitis C. Nutrition in Clinical Practice 2024; 39(3): 568 doi: 10.1002/ncp.11141
|
| 17 |
M.A. Derbak, N.V. Lizanets, O.T. Hanych, V.V. Mashura, H.Y. Mashura, O.V. Ustych, L.M. Rostoka. Lipid metabolism in patients with chronic hepatitis C, non-alcoholic fatty liver disease and obesity under the influence of treatment. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2024; 20(2): 93 doi: 10.22141/2224-0721.20.2.2024.1369
|
| 18 |
Apichat Kaewdech, Pimsiri Sripongpun. Navigating the Nomenclature of Liver Steatosis: Transitioning from NAFLD to MAFLD and MASLD - Understanding Affinities and Differences. Siriraj Medical Journal 2024; 76(4): 234 doi: 10.33192/smj.v76i4.267556
|
| 19 |
Óscar Brochado-Kith, Alicia Gómez Sanz, Luis Miguel Real, Javier Crespo García, Pablo Ryan Murúa, Juan Macías, Joaquín Cabezas González, Jesús Troya, Juan Antonio Pineda, María Teresa Arias Loste, Victorino Díez Viñas, María Ángeles Jiménez-Sousa, Luz María Medrano de Dios, Isabel Cuesta De la Plaza, Sara Monzón Fernández, Salvador Resino García, Amanda Fernández-Rodríguez. MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection. Journal of Clinical Medicine 2019; 8(6): 849 doi: 10.3390/jcm8060849
|
| 20 |
Giovanni Guaraldi, Jovana Milic. Vitamin E as a ‘bridge’ therapy for nonalcoholic steatohepatits in HIV: what is waiting on the other side of the bridge?. AIDS 2020; 34(2): 317 doi: 10.1097/QAD.0000000000002413
|
| 21 |
Tomoya Sano, Keisuke Amano, Tatsuya Ide, Keiji Yokoyama, Kazunori Noguchi, Hiroki Nakamura, Hiroshi Isoda, Miki Ohno, Miki Shirachi, Yasuyo Morita, Yoichi Yano, Shuji Sumie, Toshihiro Kawaguchi, Reiichiro Kuwahara, Teruko Arinaga‐Hino, Hirokazu Takahashi, Satoshi Shakado, Fumihito Hirai, Takumi Kawaguchi. A combination of hepatic encephalopathy and body mass index was associated with the point of no return for improving liver functional reserve after sofosbuvir/velpatasvir treatment in patients with hepatitis C virus‐related decompensated cirrhosis. Hepatology Research 2023; 53(1): 26 doi: 10.1111/hepr.13837
|
| 22 |
Yoshimasa Tokuchi, Goki Suda, Naoki Kawagishi, Masatsugu Ohara, Risako Kohya, Takashi Sasaki, Tomoka Yoda, Osamu Maehara, Shunsuke Ohnishi, Akinori Kubo, Sonoe Yoshida, Qingjie Fu, Zijian Yang, Shunichi Hosoda, Takashi Kitagataya, Kazuharu Suzuki, Masato Nakai, Takuya Sho, Mitsuteru Natsuizaka, Koji Ogawa, Naoya Sakamoto. Hepatitis C virus eradication by direct‐acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low‐density lipoprotein cholesterolemia without an increase in body weight. Hepatology Research 2023; 53(7): 595 doi: 10.1111/hepr.13899
|
| 23 |
Mona H. Ismail. Beyond genotype‐4: Direct‐acting antiviral agents in patients with chronic hepatitis C infection from the Eastern Province of Saudi Arabia. Health Science Reports 2024; 7(1) doi: 10.1002/hsr2.1795
|
| 24 |
Martina Spaziante, Gloria Taliani, Giulia Marchetti, Alessandro Tavelli, Miriam Lichtner, Antonella Cingolani, Stefania Cicalini, Elisa Biliotti, Enrico Girardi, Andrea Antinori, Massimo Puoti, Antonella d’Arminio Monforte, Alessandro Cozzi-Lepri. Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study. Viruses 2021; 13(7): 1402 doi: 10.3390/v13071402
|
| 25 |
María Fernanda Guerra, Javier Ampuero, Manuel Romero‐Gómez. Clinical Dilemmas in Viral Liver Disease. 2020; : 59 doi: 10.1002/9781119533481.ch10
|
| 26 |
Anca Trifan, Tudor Cuciureanu, Robert Nastasa, Ermina Stratina, Sebastian Zenovia, Cristina Maria Muzica, Laura Huiban, Ana-Maria Singeap, Stefan Chiriac, Catalin Sfarti, Camelia Cojocariu, Irina Girleanu, Horia Minea, Remus Stafie, Adrian Rotaru, Carol Stanciu. Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus Infection. Life 2023; 13(2): 534 doi: 10.3390/life13020534
|
| 27 |
Gehan S. Seifeldein, Elham A. Hassan, Hala M. Imam, Rania Makboul, Naglaa K. Idriss, Marwa A. Gaber, Reem M. Elkady. Quantitative MDCT and MRI assessment of hepatic steatosis in genotype 4 chronic hepatitis C patients with fibrosis. Egyptian Journal of Radiology and Nuclear Medicine 2021; 52(1) doi: 10.1186/s43055-021-00590-2
|
| 28 |
Mazen Noureddin, Jean L. Chan, Katherine Barradas, Lara Dimick-Santos, Elmer Schabel, Stephanie O. Omokaro, Frank A. Anania, Robert P. Myers, Veronica Miller, Arun J. Sanyal, Naga Chalasani, Frank A. Anania, Jasmohan Bajaj, Katherine Barradas, Annalisa Berzigotti, Pascal Birman, Jaime Bosch, Ashley Brower, Dania Calboli, Naga Chalasani, Jean L. Chan, William Charlton, Klara Dickinson, Lara Dimick-Santos, Claudia Filozof, Mikael F. Forsgren, Michael Fuchs, Guadalupe Garcia-Tsao, Juan Gonzalez-Abraldes, Hans-Juergen Gruss, Morten Hansen, Suneil Hosman, Joanne Imperial, David Jones, Gadi Lalazar, Olof Dahlqvist Leinhard, Erica Lyons, Brian McColgan, Ruby Mehta, Peter Mesenbrink, Veronica Miller, Rob Myers, Mazen Noureddin, Stephanie O. Omokaro, Veronica Pei, Vlad Ratziu, Arie Regev, Robert Riccio, Arun Sanyal, Elmer Schabel, Suna Seo, Alastair Smith, Peter Szitanyi, Peter Traber. Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum. Gastroenterology 2020; 159(2): 422 doi: 10.1053/j.gastro.2020.04.039
|
| 29 |
Busara Songtanin, Kenneth Nugent. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis C Virus Infection. Biology 2022; 12(1): 23 doi: 10.3390/biology12010023
|
| 30 |
Chih-Hsuan Luan, Pin-Shuo Su, Chi-Jen Chu, Chung-Chi Lin, Chien-Wei Su, Shou-Dong Lee, Yuan-Jen Wang, Fa-Yauh Lee, Yi-Hsiang Huang, Ming-Chih Hou. Residual risk of hepatocellular carcinoma development for chronic hepatitis C patients treated by all oral direct-acting antivirals with sustained virological response. Journal of the Chinese Medical Association 2023; 86(9): 795 doi: 10.1097/JCMA.0000000000000965
|
| 31 |
Francesco Negro. Residual risk of liver disease after hepatitis C virus eradication. Journal of Hepatology 2021; 74(4): 952 doi: 10.1016/j.jhep.2020.11.040
|
| 32 |
Shivaram P. Singh, Prajna Anirvan, Reshu Khandelwal, Sanjaya K. Satapathy. Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00174
|
| 33 |
Nicole Loo, Bryan Hanysak, Jena Mann, Ruben Ramirez, Jae Kim, Robert Mitchell, Timothy Van Frank, Richard Guerrero, Kim Hinojosa, Kimberley Christensen, Lisa D. Pedicone, Naim Alkhouri, Jennifer Wells, Carmen Landaverde, Fabian Rodas, Eric Lawitz, Fred Poordad. Real-world observational experience with direct-acting antivirals for hepatitis C: baseline resistance, efficacy, and need for long-term surveillance. Medicine 2019; 98(26): e16254 doi: 10.1097/MD.0000000000016254
|
| 34 |
Mario Frías, Antonio Rivero-Juárez, Isabel Machuca, Ángela Camacho, Antonio Rivero. The outlook for precision medicine for the treatment of chronic hepatitis C infection: challenges and opportunities. Expert Review of Precision Medicine and Drug Development 2020; 5(4): 253 doi: 10.1080/23808993.2020.1764346
|
| 35 |
Jürgen Kurt Rockstroh. Noninvasive Markers for Monitoring Fibrosis Regression After Hepatitis C Virus Cure: What Do They Promise?. Clinical Infectious Diseases 2021; 73(3): 478 doi: 10.1093/cid/ciaa698
|
| 36 |
Annalisa Cespiati, Inês Coelho Rodrigues, Inês Santos, Sara Policarpo, Sofia Carvalhana, Anna Ludovica Fracanzani, Helena Cortez‐Pinto. Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: A systematic review. Liver International 2024; 44(5): 1075 doi: 10.1111/liv.15876
|
| 37 |
Oana Irina Gavril, Lidia Iuliana Arhire, Otilia Gavrilescu, Mihaela Dranga, Oana Barboi, Radu Sebastian Gavril, Roxana Popescu, Cristina Cijevschi Prelipcean, Anca-Victorita Trifan, Catalina Mihai. Role of PNPLA3 in the Assessment and Monitoring of Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C Infection Who Achieved a Sustained Virologic Response. Medicina 2021; 57(11): 1153 doi: 10.3390/medicina57111153
|
| 38 |
Jihane N. Benhammou, Andrew M. Moon, Joseph R. Pisegna, Feng Su, Philip Vutien, Cynthia A. Moylan, George N. Ioannou. Nonalcoholic Fatty Liver Disease Risk Factors Affect Liver-Related Outcomes After Direct-Acting Antiviral Treatment for Hepatitis C. Digestive Diseases and Sciences 2021; 66(7): 2394 doi: 10.1007/s10620-020-06457-2
|
| 39 |
Mohamed Shengir, Mohamed Elgara, Giada Sebastiani. Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond. World Journal of Gastroenterology 2021; 27(17): 1959-1972 doi: 10.3748/wjg.v27.i17.1959
|
| 40 |
Duanghathai Pasanta, Khin Thandar Htun, Jie Pan, Montree Tungjai, Siriprapa Kaewjaeng, Hongjoo Kim, Jakrapong Kaewkhao, Suchart Kothan. Magnetic Resonance Spectroscopy of Hepatic Fat from Fundamental to Clinical Applications. Diagnostics 2021; 11(5): 842 doi: 10.3390/diagnostics11050842
|
| 41 |
Yasser Fouad, Mohamed Alboraie, Gamal Shiha. Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease. Hepatology International 2024; 18(S2): 827 doi: 10.1007/s12072-024-10704-3
|
| 42 |
Perica Davitkov, Kyle Hoffman, Yngve Falck-Ytter, Brigid Wilson, Gjorgje Stojadinovikj, Donald D. Anthony, Stanley Martin Cohen, Gregory Cooper, Yuh-Shin Chang. Increasing liver stiffness is associated with higher incidence of hepatocellular carcinoma in hepatitis C infection and non-alcoholic fatty liver disease–A population-based study. PLOS ONE 2023; 18(1): e0280647 doi: 10.1371/journal.pone.0280647
|
| 43 |
Napas Rodprasert, Tinn Hongboontry, Chitchanok Cherdchoochart, Roongruedee Chaiteerakij. Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after Successful Treatment with Direct-Acting Antivirals. Medicina 2023; 59(3): 602 doi: 10.3390/medicina59030602
|
| 44 |
Mirella Fraquelli, Ilaria Fanetti, Andrea Costantino. Elastography of the Liver and Beyond. 2021; : 119 doi: 10.1007/978-3-030-74132-7_9
|
| 45 |
Omar A. Saldarriaga, Bradley Dye, Judy Pham, Timothy G. Wanninger, Daniel Millian, Michael Kueht, Benjamin Freiberg, Netanya Utay, Heather L. Stevenson. Comparison of liver biopsies before and after direct-acting antiviral therapy for hepatitis C and correlation with clinical outcome. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-93881-7
|
| 46 |
Marie Ongaro, Francesco Negro. Hépatite B et C: une mise à jour sur lʼhépatite virale chronique. Schweizer Gastroenterologie 2022; 3(1): 19 doi: 10.1007/s43472-022-00062-6
|
| 47 |
Chiara Masetti, Ana Lleo, Matteo Colombo, Massimo Colombo, Alessio Aghemo. Postsustained Virological Response Management in Hepatitis C Patients. Seminars in Liver Disease 2020; 40(03): 233 doi: 10.1055/s-0040-1702944
|
| 48 |
Dina Sweed, Nanis Shawky Holah, Esraa Karman, Nancy Asaad, Shereen Mahmoud. Farnesoid X receptor in chronic liver diseases: an immunohistochemical study. Journal of Immunoassay and Immunochemistry 2023; 44(5-6): 381 doi: 10.1080/15321819.2023.2242920
|
| 49 |
Julia B Balmaceda, Julia Aepfelbacher, Olivia Belliveau, Chloe S Chaudhury, Cheryl Chairez, Mary McLaughlin, Rachel Silk, Chloe Gross, Sarah Kattakuzhy, Elana Rosenthal, Shyam Kottilil, David E Kleiner, Colleen Hadigan. Long-Term Changes in Hepatic Fibrosis following Hepatitis C Viral Clearance in Patients with and without HIV. Antiviral Therapy 2019; 24(6): 451 doi: 10.3851/IMP3327
|
| 50 |
Maria Alejandra Luna-Cuadros, Hao-Wei Chen, Hira Hanif, Mukarram Jamat Ali, Muzammil Muhammad Khan, Daryl Tan-Yeung Lau. Risk of hepatocellular carcinoma after hepatitis C virus cure. World Journal of Gastroenterology 2022; 28(1): 96-107 doi: 10.3748/wjg.v28.i1.96
|
| 51 |
A. Sirinawasatien, T. Techasirioangkun, Masanao Nakamura. The Prevalence and Determinants of Hepatic Steatosis Assessed by Controlled Attenuation Parameter in Thai Chronic Hepatitis C Patients. Gastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/8814135
|
| 52 |
Yun-Cheng Hsieh, Kuei-Chuan Lee, Chien-Wei Su, Ken-Hsin Lan, Teh-Ia Huo, Yuan-Jen Wang, Hui-Chun Huang, Han-Chieh Lin, Chi-Jen Chu, Yi-Hsiang Huang, Ming-Chih Hou. Persistent liver inflammation in chronic hepatitis C patients with advanced fibrosis after direct-acting antivirals induced sustained virological response. Journal of the Chinese Medical Association 2021; 84(5): 472 doi: 10.1097/JCMA.0000000000000517
|
| 53 |
Maja Ružić, Rinaldo Pellicano, Milotka Fabri, Francesco Luzza, Luigi Boccuto, Snežana Brkić, Ludovico Abenavoli. Hepatitis C virus-induced hepatocellular carcinoma: a narrative review. Panminerva Medica 2018; 60(4) doi: 10.23736/S0031-0808.18.03472-9
|
| 54 |
Ahmed El-Ghandour, Tarek Youssif, Wesam Ibrahim, Hoda Ahmed Abdelsattar, Somia Abd elhamid Bawady, Mariam Wagih, Sarah El-Nakeep. The effect of different direct antivirals on hepatic steatosis in nondiabetic and naïve hepatitis C-infected Egyptian patients. The Egyptian Journal of Internal Medicine 2023; 35(1) doi: 10.1186/s43162-023-00197-1
|
| 55 |
Po-Ke Hsu, Li-Sha Wu, Wei-Wen Su, Pei-Yuan Su, Yang-Yuan Chen, Yu-Chun Hsu, Hsu-Heng Yen, Chia-Lin Wu, Jee-Fu Huang. Comparing the controlled attenuation parameter using FibroScan and attenuation imaging with ultrasound as a novel measurement for liver steatosis. PLOS ONE 2021; 16(10): e0254892 doi: 10.1371/journal.pone.0254892
|
| 56 |
Mazen Noureddin, Aarshi Vipani, Catherine Bresee, Tsuyoshi Todo, Irene K. Kim, Naim Alkhouri, Veronica Wendy Setiawan, Tram Tran, Walid S. Ayoub, Shelly C. Lu, Andrew S. Klein, Vinay Sundaram, Nicholas N. Nissen. NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances. American Journal of Gastroenterology 2018; 113(11): 1649 doi: 10.1038/s41395-018-0088-6
|
| 57 |
Sergio Estefan, Carlos Eduardo Brandão-Melo, Cintia Marques dos Santos Silva, Danilo Cosme Klein Gomes, Paula Cardoso, Marcia Helena S. Costa. Metabolic Evaluation in Patients With Hepatitis C Treated With Direct Antiviral Agents. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.631600
|